0.7 |
2.1 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.5 |
1.6 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.4 |
1.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 |
1.0 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
0.3 |
2.0 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
0.3 |
3.4 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 |
0.3 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
0.3 |
0.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.3 |
2.7 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 |
0.8 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 |
0.7 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 |
1.5 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
0.2 |
1.1 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.2 |
1.3 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
0.2 |
0.6 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 |
0.6 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.2 |
0.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 |
0.6 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
0.2 |
0.6 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
0.2 |
0.8 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 |
0.7 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
0.2 |
1.5 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
0.2 |
4.5 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 |
1.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 |
1.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.2 |
0.7 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
0.2 |
1.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
0.2 |
2.7 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 |
0.5 |
GO:0060023 |
soft palate development(GO:0060023) |
0.2 |
0.6 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.1 |
0.4 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 |
0.5 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 |
3.9 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 |
0.4 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
0.1 |
1.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
0.1 |
0.5 |
GO:0072592 |
regulation of integrin biosynthetic process(GO:0045113) oxygen metabolic process(GO:0072592) |
0.1 |
0.7 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
0.1 |
0.6 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
0.1 |
0.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in axis elongation(GO:0060028) |
0.1 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 |
0.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 |
0.3 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 |
0.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 |
0.4 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
0.1 |
0.3 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 |
0.3 |
GO:0045006 |
DNA deamination(GO:0045006) |
0.1 |
3.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 |
0.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) progesterone secretion(GO:0042701) cerebellum vasculature development(GO:0061300) |
0.1 |
0.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
0.1 |
0.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
0.1 |
0.6 |
GO:0090399 |
replicative senescence(GO:0090399) |
0.1 |
0.6 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
0.1 |
1.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
0.1 |
1.0 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
0.1 |
0.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 |
0.5 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
0.1 |
0.2 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
0.1 |
0.4 |
GO:0033762 |
response to glucagon(GO:0033762) |
0.1 |
0.4 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 |
0.4 |
GO:0040031 |
snRNA modification(GO:0040031) |
0.1 |
0.9 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
0.1 |
1.7 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
0.1 |
1.1 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
0.1 |
0.5 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
0.1 |
0.2 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 |
2.6 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
0.1 |
0.6 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 |
1.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.1 |
0.5 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 |
0.8 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.1 |
0.3 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 |
0.2 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 |
0.5 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 |
0.2 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 |
1.1 |
GO:0007530 |
sex determination(GO:0007530) |
0.1 |
0.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
0.1 |
0.7 |
GO:0015825 |
L-serine transport(GO:0015825) |
0.1 |
0.4 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
0.1 |
0.9 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
0.1 |
0.2 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
0.1 |
0.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
0.1 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 |
0.2 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
0.1 |
0.2 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
0.1 |
1.2 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
0.1 |
0.4 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
0.1 |
0.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
0.1 |
0.9 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 |
0.3 |
GO:0048840 |
otolith development(GO:0048840) |
0.1 |
0.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
0.1 |
0.3 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 |
0.4 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 |
0.9 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
0.0 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 |
0.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
0.0 |
0.6 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 |
0.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 |
0.2 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 |
0.2 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 |
0.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.0 |
0.0 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.0 |
1.3 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
0.0 |
0.4 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
0.0 |
0.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
0.0 |
0.2 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 |
0.3 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
0.0 |
0.2 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
0.0 |
0.2 |
GO:0015744 |
succinate transport(GO:0015744) |
0.0 |
0.9 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
0.0 |
0.1 |
GO:0046544 |
development of secondary male sexual characteristics(GO:0046544) |
0.0 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
0.0 |
1.6 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
0.0 |
0.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 |
0.2 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
0.0 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 |
0.3 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 |
0.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
0.0 |
1.4 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.0 |
1.5 |
GO:0019228 |
neuronal action potential(GO:0019228) |
0.0 |
0.7 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
0.0 |
0.2 |
GO:0032328 |
amino-acid betaine transport(GO:0015838) alanine transport(GO:0032328) |
0.0 |
0.4 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 |
2.5 |
GO:0006342 |
chromatin silencing(GO:0006342) |
0.0 |
0.4 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
0.0 |
0.2 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
0.0 |
0.4 |
GO:0060065 |
uterus development(GO:0060065) |
0.0 |
1.0 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
0.0 |
0.1 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
0.0 |
0.2 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 |
0.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 |
1.4 |
GO:0008347 |
glial cell migration(GO:0008347) |
0.0 |
0.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 |
0.7 |
GO:0071385 |
cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 |
0.4 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
0.0 |
0.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
0.0 |
0.6 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
0.0 |
0.3 |
GO:0003334 |
keratinocyte development(GO:0003334) |
0.0 |
0.1 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
0.0 |
0.9 |
GO:0051693 |
actin filament capping(GO:0051693) |
0.0 |
0.3 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
0.0 |
0.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
0.0 |
0.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 |
0.9 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
0.0 |
0.3 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
0.0 |
0.5 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
0.0 |
0.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) |
0.0 |
0.3 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
0.0 |
0.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 |
1.3 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 |
0.1 |
GO:0000389 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) mRNA 3'-splice site recognition(GO:0000389) |
0.0 |
0.3 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 |
0.2 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.0 |
2.1 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
0.0 |
1.6 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) DNA integrity checkpoint(GO:0031570) |
0.0 |
1.4 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
0.0 |
0.2 |
GO:0060746 |
parental behavior(GO:0060746) |
0.0 |
0.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
0.0 |
0.1 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
0.0 |
0.1 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 |
0.2 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
0.0 |
0.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 |
0.0 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
0.0 |
0.1 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.0 |
0.4 |
GO:0060325 |
face morphogenesis(GO:0060325) |
0.0 |
0.1 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 |
0.0 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 |
0.2 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
0.0 |
0.3 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
0.0 |
0.4 |
GO:0031648 |
protein destabilization(GO:0031648) |
0.0 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
0.0 |
0.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 |
0.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 |
0.3 |
GO:0003016 |
respiratory system process(GO:0003016) |
0.0 |
0.4 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
0.0 |
0.1 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |